Coronary Bifurcation Stenting (COBIS) Registry in South Korea

Samsung Medical Center1,919 enrolled

Overview

The COBIS registry is multi-center, real-world registry of drug-eluting stenting in coronary bifurcation lesions in South Korea. The aim of the study was to find out the current status of bifurcation drug-eluting stenting and determine the prognostic factors for long-term outcome in South Korea.

Study Type

OBSERVATIONAL

Enrollment

1,919

Conditions

Coronary Bifurcation Lesion

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Age \>= 18 years * Any type of de novo bifurcation lesion with a parent vessel \>= 2.5 mm and side branch\>= 2.0 mm by visual estimation * Treated with drug-eluting stent Exclusion Criteria: * Cardiogenic Shock * ST elevation MI within 48hours * Expected survival less than 1 year * Left main bifurcation * Allergy to the antiplatelets

Locations (1)

Samsung Medical Center

Seoul, South Korea

Outcomes

Primary Outcomes

Incidence of the composite outcome of all-cause death, MI, or any PCI/CABG

Time frame: 3 years

Secondary Outcomes

Incidence of stent thrombosis, and periprocedural MI

Time frame: 3 years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.